FACULTY AND PLANNING COMMITTEE

• Randall Brown, MD, PhD, Associate Professor, Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health
• Andrew Cohen, PharmD, Pharmacy Clinical Coordinator, Bellin Health
• Rose Hennessey-Garza, PhD, Fellow, Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health
• Naciye Kalafat, MD, Behavioral Health Psychiatrist, Bellin Health
• Jillian Landeck, MD, Assistant Professor, Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health
• Lynn Madden, PhD, Researcher, Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health
• Andrew Quanbeck, PhD, Assistant Professor, Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health
• Laura Sasse, ND, RN, Clinical Assistant Professor, School of Nursing, University of Wisconsin-Madison
• Sarina Schrager, MD, MS, Professor, Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health
• Nicholas Schumacher, Research Specialist, Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health
• Sheila Weix, MSN, RN, CARN, Director of Substance Abuse Services, Alcohol and Drug Recovery Centers, Marshfield Clinic
• Brad Wozney, MD, Medical Director - Population Health, Bellin Health
• Amy Yeatman, DO, Pain Management Physician, Bellin Health 

POLICY ON FACULTY AND SPONSOR DISCLOSURE

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are list below by clicking on the View Disclosures link.

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.